The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.

Omeros reported positive data from its Phase 3 clinical trial evaluating OMS302 in patients undergoing intraocular lens replacement surgery. OMS302 met its primary endpoint by demonstrating ...

The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to ...

Omeros reported positive data from the second of its two pivotal Phase 3 clinical trials evaluating OMS302 in patients undergoing intraocular lens replacement surgery. This multicenter, double-blind, ...

Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.

SEATTLE, Jan. 22, 2013 /PRNewswire/ – Omeros Corporation (OMER) today announced the successful completion of the 90-day safety database lock in the second of the Company's two pivotal Phase 3 clinical ...

Johnson & Johnson introduces the TECNIS Odyssey IOL in India, enhancing vision for cataract patients with advanced technology.

An 88-year-old man, with a history of a retained right dislocated intraocular lens and secondary lens insertion, presented to our department with reduced vision. He had undergone uncomplicated ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Nov. 14, 2003--eyeonics inc.(TM), the developer of a new class of visual enhancement systems, today announced that it has received FDA approval to market the ...

(Reuters Health) - Seniors who get new lenses implanted during cataract surgery may not only see better but also experience better sleep, suggests a new study of how light entering the eye regulates ...

Please provide your email address to receive an email when new articles are posted on . Omeros Corp. announced that the U.S. Food and Drug Administration has approved the use of phenylephrine and ...

American Hospital Supply Corp., a unit of Baxter Travenol Laboratories Inc., has received approval from the Food and Drug Administration to market two kinds of intraocular lenses that correct vision ...